Rising Concerns Over Permanent Sexual Side Effects of Common Antidepressants

An opinion article recounts a 21-year-old student who, after a short AI-driven telehealth visit, was prescribed an SSRI and later suffered lasting sexual impairments. It points out that selective serotonin reuptake inhibitors dominate U.S. antidepressant use, with prescriptions for youths rising sharply over the past two decades. While most SSRIs carry a black-box warning about suicidal risk in young people, they lack mandated alerts for post-SSRI sexual dysfunction (PSSD), a condition that can include diminished desire, numbness, and emotional blunting.

Survey data reveal that more than half of patients on certain SSRIs report reduced libido or orgasm difficulties, and the problem appears more severe in women. The article features a former patient’s account of lifelong sexual loss and urges the psychiatric community to study and disclose this risk more transparently.